Display options
Cite
Bouchahda M, Saffroy R, Karaboué A, et al. Undetectable . JCO Precis Oncol. 2020;4doi: 10.1200/PO.19.00400.
Bouchahda, M., Saffroy, R., Karaboué, A., Hamelin, J., Innominato, P., Saliba, F., Lévi, F., Bosselut, N., & Lemoine, A. (2020). Undetectable . JCO precision oncology, 4. https://doi.org/10.1200/PO.19.00400
Bouchahda, Mohamed, et al. "Undetectable ." JCO precision oncology vol. 4 (2020). doi: https://doi.org/10.1200/PO.19.00400
Bouchahda M, Saffroy R, Karaboué A, Hamelin J, Innominato P, Saliba F, Lévi F, Bosselut N, Lemoine A. Undetectable . JCO Precis Oncol. 2020 Sep 16;4. doi: 10.1200/PO.19.00400. eCollection 2020. PMID: 33015528; PMCID: PMC7529530.
Copy Download .nbib Format: NLM
Share it on

JCO Precis Oncol. 2020 Sep 16;4. doi: 10.1200/PO.19.00400. eCollection 2020.

Undetectable .

JCO precision oncology

Mohamed Bouchahda, Raphael Saffroy, Abdoulaye Karaboué, Jocelyne Hamelin, Pasquale Innominato, Faouzi Saliba, Francis Lévi, Nelly Bosselut, Antoinette Lemoine

Affiliations

  1. Medical Oncology Department, Paul Brousse Hospital, Villejuif, France.
  2. Medical Oncology Unit, Clinique du Mousseau, Evry, France.
  3. Oncogenetics Department, Assistance Publique-Hôpitaux de Paris, Paul Brousse Hospital, Université Paris-Saclay, Villejuif, France.
  4. French National Institute for Health and Medical Research (INSERM), Unit 935, Villejuif, France.
  5. Medical Oncology Unit, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France.
  6. North Wales Cancer Centre, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board, Bangor, United Kingdom.
  7. Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences, Warwick Medical School, Coventry, United Kingdom.
  8. Centre Hépato Biliaire, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France.

PMID: 33015528 PMCID: PMC7529530 DOI: 10.1200/PO.19.00400

Abstract

PURPOSE: Combining cetuximab with chemotherapy provides clinical benefit to 60% of the patients with

MATERIALS AND METHODS: The occurrence of Kirsten rat sarcoma viral oncogene homolog (

RESULTS: Of 16 registered patients, 11 were male and five female. They were age 48 to 81 years, and they had unresectable metastatic adenocarcinoma from the colon (n = 11) or rectum (n = 5), with a median of two metastatic sites. They had received a median number of three previous chemotherapy protocols. Plasma genotyping identified

CONCLUSION: Patients with

© 2020 by American Society of Clinical Oncology.

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I

References

  1. Meta Gene. 2016 May 09;9:110-9 - PubMed
  2. JAMA. 2017 Jun 20;317(23):2392-2401 - PubMed
  3. J Clin Oncol. 2007 Apr 20;25(12):1539-44 - PubMed
  4. JAMA Oncol. 2017 Feb 1;3(2):194-201 - PubMed
  5. Lancet Oncol. 2015 May;16(5):499-508 - PubMed
  6. Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9 - PubMed
  7. JCO Precis Oncol. 2019 Mar 28;3: - PubMed
  8. Anticancer Res. 2019 Jan;39(1):1-16 - PubMed
  9. Int J Cancer. 2017 Sep 1;141(5):887-896 - PubMed
  10. Ann Oncol. 2019 Oct 1;30(10):1580-1590 - PubMed
  11. Ann Oncol. 2017 Sep 1;28(9):2149-2159 - PubMed
  12. Cancer Chemother Pharmacol. 2010 Aug;66(3):605-9 - PubMed
  13. Eur J Cancer. 2009 Jan;45(2):228-47 - PubMed
  14. Cell. 2017 Feb 9;168(4):613-628 - PubMed
  15. Lancet Oncol. 2010 Aug;11(8):753-62 - PubMed
  16. Lancet Oncol. 2014 Sep;15(10):1065-75 - PubMed
  17. J Clin Oncol. 2015 Mar 1;33(7):692-700 - PubMed
  18. Mol Cancer. 2017 Feb 16;16(1):41 - PubMed
  19. J Clin Oncol. 2008 May 10;26(14):2311-9 - PubMed
  20. Clin Cancer Res. 2015 Dec 15;21(24):5469-79 - PubMed
  21. Clin Colorectal Cancer. 2018 Dec;17(4):313-319 - PubMed
  22. Sci Transl Med. 2014 Feb 19;6(224):224ra24 - PubMed
  23. Cancers (Basel). 2019 Jan 04;11(1): - PubMed
  24. Ann Oncol. 2017 Jun 1;28(6):1325-1332 - PubMed
  25. Mol Oncol. 2019 Sep;13(9):1827-1835 - PubMed
  26. J Clin Oncol. 2012 Oct 1;30(28):3499-506 - PubMed
  27. Eur J Cancer. 2015 Sep;51(13):1704-13 - PubMed
  28. Breast Cancer Res. 2014 May 20;16(3):210 - PubMed
  29. Nat Rev Clin Oncol. 2017 Sep;14(9):531-548 - PubMed
  30. Int J Biol Markers. 2017 Oct 31;32(4):e474-e477 - PubMed
  31. Ann Oncol. 2016 Sep;27(9):1746-53 - PubMed
  32. N Biotechnol. 2020 Mar 25;55:30-35 - PubMed
  33. Adv Exp Med Biol. 2018;1110:113-131 - PubMed
  34. Ann Oncol. 2017 Jun 1;28(6):1294-1301 - PubMed
  35. Med Oncol. 2011 Dec;28 Suppl 1:S253-8 - PubMed
  36. N Engl J Med. 2013 Sep 12;369(11):1023-34 - PubMed

Publication Types